Unbiased AI-powered news
1 stories related to this topic, newest first.
theepochtimes.comThe Food and Drug Administration approved enlicitide, sold as Lipfendra, on Thursday. The daily pill inhibits PCSK9 and carries a lower list price than existing injectable treatments.